Page last updated: 2024-10-27

fluorouracil and Anterior Cervical Pain

fluorouracil has been researched along with Anterior Cervical Pain in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research Excerpts

ExcerptRelevanceReference
"We report on an 86-year-old woman with colon cancer with liver metastasis who was treated with 5-fluorouracil, folinic acid, and bevacizumab."1.39Cervical extravasation of bevacizumab. ( Boudou-Rouquette, P; Brezault, C; Chaussade, S; Coriat, R; Dhooge, M; Dréanic, J; Goldwasser, F; Mir, O; Perkins, G, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dréanic, J1
Coriat, R1
Mir, O1
Perkins, G1
Boudou-Rouquette, P1
Brezault, C1
Dhooge, M1
Goldwasser, F1
Chaussade, S1
Partridge, S1
Leslie, M1
Irvine, A1

Other Studies

2 other studies available for fluorouracil and Anterior Cervical Pain

ArticleYear
Cervical extravasation of bevacizumab.
    Anti-cancer drugs, 2013, Volume: 24, Issue:4

    Topics: Adenocarcinoma; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antin

2013
Infusional 5-fluorouracil can be a pain in the neck: A case for repositioning displaced Hickman lines.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1999, Volume: 11, Issue:4

    Topics: Aged; Antimetabolites, Antineoplastic; Catheterization, Central Venous; Fluorouracil; Humans; Infusi

1999